Report on Vaccine Equity and Distribution Research in Ghana

Less than a year after the first wave of COVID-19
was reported in Wuhan, China, the
international scientific community launched its
first preventive SARS-Cov-2 (COVID-19)
vaccines. In December 2020, the United Kingdom
began administering index doses of this
vaccine, followed by the worldwide approval and
implementation of several other candidate
vaccines.
There have been growing concerns about the
potential for an unequal distribution of vaccines
around the world, which could have a negative
impact on global health security and health
outcomes, as a result of this innovation.
Phase 2 of CTAP’s COVID-19 Vaccine Evolution
and Hesitancy Study sought to outline Ghana’s
COVID-19 vaccine evolution, hesitancy, current
vaccination levels and distribution, adequacy
and related emerging issues in order to inform
civil society advocacy for vaccine equity in
Ghana.

Menu

Pin It on Pinterest

Share This